A PHASE 1, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED PHARMACOKINETIC STUDY EVALUATING ORAL BX002-A BACTERIOPHAGE THERAPY FOR INFLAMMATORY BOWEL DISEASE

Urania Rappo  ¹     Ariel Cohen  ²     Edith Kario     Merav Bassan     Sailaja Puttagunta    
¹ BiomX, Inc., Branford, United States
² BiomX, Ltd., Ness Ziona, Israel

Topic
Gut Microbiota, IBD, Immunology

Session
Diet, microbiota & more

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)